Results

Total Results: 4,731 records

Showing results for "secondary".

  1. www.ahrq.gov/sites/default/files/wysiwyg/data/SyH-DR-Codebook.pdf
    December 01, 2023 - However, secondary diagnosis codes (ICD_DX_CD_2– ICD_DX_CD_25) are randomly rearranged to fill ICD_DX_CD … _2–ICD_DX_CD_X, where X is the number of nonmissing and valid secondary diagnoses. … Users should therefore not assign any analytic meaning to the ordering of the secondary DX codes.
  2. effectivehealthcare.ahrq.gov/sites/default/files/pdf/major-depressive-disorder_research-protocol.pdf
    November 24, 2014 - Setting Primary, secondary, and tertiary care outpatient settings Source: www.effectivehealthcare.ahrq.gov … searches will be updated after the draft report goes out for peer review Settings • Primary, secondary … exclusion criteria: Study design Exclusions: Add: • Post hoc analyses and pooled studies • Secondary
  3. hcup-us.ahrq.gov/reports/statbriefs/sb243-Severe-Maternal-Morbidity-Delivery-Trends-Disparities.pdf
    February 01, 2018 - Secondary diagnoses are concomitant conditions that coexist at the time of admission or develop during … All-listed diagnoses include the principal diagnosis plus these additional secondary conditions. … delivery was vaginal or by cesarean section • Greater than or equal to 5 days, if the delivery was a secondary
  4. hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2013_MaskedStats_Core_Weighted.PDF
    January 01, 2013 - 0.46539 PAY1 Primary expected payer (uniform) 29534850 46868 1 6 2.588418 0.012723 2.56345 2.61339 PAY2 Secondary … 25,385 0.02 40: Multiple myeloma 9,934 0.01 41: Cancer; other and unspecified primary 3,699 0.00 42: Secondary … disease) 66,109 0.05 98: Essential hypertension 796,097 0.59 99: Hypertension with complications and secondary
  5. hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2012_MaskedStats_Core_Weighted.PDF
    January 01, 2012 - 0.50583 PAY1 Primary expected payer (uniform) 31046384 44636 1 6 2.614997 0.014240 2.58705 2.64294 PAY2 Secondary … 24,519 0.02 40: Multiple myeloma 9,394 0.01 41: Cancer; other and unspecified primary 3,490 0.00 42: Secondary … disease) 63,848 0.05 98: Essential hypertension 777,837 0.58 99: Hypertension with complications and secondary
  6. hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2012_MaskedStats_Core.PDF
    January 01, 2012 - 28485.35 10203.91 PAY1 : Primary expected payer (uniform) 31,046,384 44,636 1.00 6.00 2.62 1.29 PAY2 : Secondary … 5,660 0.02 40: Multiple myeloma 2,190 0.01 41: Cancer; other and unspecified primary 811 0.00 42: Secondary … disease) 14,786 0.05 98: Essential hypertension 183,721 0.59 99: Hypertension with complications and secondary
  7. hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2010_MaskedStats_Core_Weighted.PDF
    January 01, 2010 - 29, 2012 4 Means of Continuous Data Elements Variable Label N N Miss Min Max Mean Std Error PAY2 Secondary … 23,705 0.02 40: Multiple myeloma 9,315 0.01 41: Cancer; other and unspecified primary 3,717 0.00 42: Secondary … disease) 63,197 0.05 98: Essential hypertension 723,377 0.56 99: Hypertension with complications and secondary
  8. hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2011v2_MaskedStats_Core_Weighted.PDF
    November 03, 2014 - PAY1 Primary expected payer (uniform) 28690937 130,614,412 1 6 2.603080 0.012284 2.57897 2.62719 PAY2 Secondary … 24,424 0.02 40: Multiple myeloma 9,269 0.01 41: Cancer; other and unspecified primary 3,867 0.00 42: Secondary … disease) 64,858 0.05 98: Essential hypertension 749,508 0.57 99: Hypertension with complications and secondary
  9. hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2014_MaskedStats_Core_Weighted.PDF
    January 01, 2014 - Mean PAY1 Primary expected payer (uniform) 30973056 53361 1 6 2.501290 0.011892 2.47795 2.52463 PAY2 Secondary … 25,213 0.02 40: Multiple myeloma 9,737 0.01 41: Cancer; other and unspecified primary 3,738 0.00 42: Secondary … disease) 67,490 0.05 98: Essential hypertension 831,977 0.60 99: Hypertension with complications and secondary
  10. hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2011_MaskedStats_Core_Weighted.PDF
    January 01, 2011 - 29,421,411 0 0 19 0.49 0.01 PAY1 Primary expected payer (uniform) 29,320,224 101,187 1 6 2.60 0.01 PAY2 Secondary … 24,938 0.02 40: Multiple myeloma 9,506 0.01 41: Cancer; other and unspecified primary 3,887 0.00 42: Secondary … disease) 66,060 0.05 98: Essential hypertension 742,997 0.57 99: Hypertension with complications and secondary
  11. hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2013_MaskedStats_Core.PDF
    January 01, 2013 - 28238.66 10136.13 PAY1 : Primary expected payer (uniform) 29,534,850 46,868 1.00 6.00 2.59 1.29 PAY2 : Secondary … 5,456 0.02 40: Multiple myeloma 2,189 0.01 41: Cancer; other and unspecified primary 799 0.00 42: Secondary … disease) 14,312 0.05 98: Essential hypertension 177,753 0.60 99: Hypertension with complications and secondary
  12. hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2009_MaskedStats_Core_Weighted.PDF
    January 01, 2009 - 28,861,047 0 0 15 0.43 0.01 PAY1 Primary expected payer (uniform) 28,744,966 116,081 1 6 2.67 0.01 PAY2 Secondary … 24,297 0.02 40: Multiple myeloma 9,128 0.01 41: Cancer; other and unspecified primary 3,382 0.00 42: Secondary … disease) 60,617 0.05 98: Essential hypertension 683,201 0.53 99: Hypertension with complications and secondary
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-women-diagnosis_executive.pdf
    June 01, 2012 - In secondary analyses, we explored a broader patient population by including those studies that had … anatomy (nonobstructive or obstructive) in symptomatic patients lead to better implementation of secondary … could lead to further testing to establish the diagnosis of CAD as well as lead to more attention to secondary
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/insulin-blood-sugar-2010_research-protocol.pdf
    January 01, 2010 - therapy/sensor use Frequency of professional or allied health visits Primary Hemoglobin A1c Secondary … Intermediate health outcomes Primary  Hemoglobin A1c Secondary  Hyperglycemia  Weight gain … adjusting insulin therapy  Adherence to insulin therapy/sensor use Primary  Hemoglobin A1c Secondary
  15. digital.ahrq.gov/sites/default/files/docs/citation/r21hs023863-cartmell-final-report-2018.pdf
    January 01, 2018 - Methods: To examine the TDTS effect on readmission and costs, three secondary datasets were linked (EHR … METHODS Intervention A secondary data analysis was conducted to evaluate the MUSC TDTS. … First, the study was conducted using secondary data to evaluate the effects of an evidence-based TDTS
  16. hcup-us.ahrq.gov/db/nation/kid/DataElements_KID_Hospital_2000.pdf
    January 01, 2000 - .� In-hospital births (HOSPBRTH = 1) are defined by two conditions: − A principal or secondary diagnosis … Normal Newborn.� In-hospital births (HOSPBRTH = 1) are defined by two conditions: − A principal or secondary
  17. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/72739/psn-pdf
    February 10, 2021 - venous thromboembolism (VTE), pulmonary embolism (PE) was considered based on her limited mobility secondary … overutilization--including contrast hypersensitivity reactions and nephropathy, and risk of malignancy secondary
  18. digital.ahrq.gov/sites/default/files/docs/publication/r21hs018749-nease-final-report-2013.pdf
    January 01, 2013 - To assess this, a secondary analysis was performed. … Secondary models of mean unit testing costs Specialty Baseline unit cost Change per quarter
  19. www.ahrq.gov/sites/default/files/2024-01/kesselheim-report.pdf
    January 01, 2024 - Evaluation and Outcomes Research at Division of Pharmacoepidemiology and Pharmacoeconomics • Co-mentor (secondary … A diverse set of large secondary databases was used to identify patterns of on- and off- label use of
  20. www.ahrq.gov/sites/default/files/2024-01/taekman-report.pdf
    January 01, 2024 - Secondary objectives were (1) to determine whether there were measurable changes in skill across any … With respect to secondary objectives, we identified a skills “ceiling effect” for participants who pre-tested